Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Effectiveness Analysis in Contrast Nephropathy

NCT03004950 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT03004950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03004950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Effectiveness Analysis in Contrast Nephropathy
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
October 1, 2016
Completion date
June 30, 2023
Enrollment
922 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, chronic kidney disease, coronary (artery); disease, kidney diseases